These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9144342)
1. Plasminogen activator system in osteoclasts. Yang JN; Allan EH; Anderson GI; Martin TJ; Minkin C J Bone Miner Res; 1997 May; 12(5):761-8. PubMed ID: 9144342 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators and inhibitors are transcribed during early macaque implantation. Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823 [TBL] [Abstract][Full Text] [Related]
3. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. Nip J; Rabbani SA; Shibata HR; Brodt P J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755 [TBL] [Abstract][Full Text] [Related]
4. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta. Nishida Y; Hayashi Y; Imai Y; Itoh H Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
6. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. Teesalu T; Blasi F; Talarico D Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098 [TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related]
8. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771 [TBL] [Abstract][Full Text] [Related]
9. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor. Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307 [TBL] [Abstract][Full Text] [Related]
11. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521 [TBL] [Abstract][Full Text] [Related]
12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
13. Regulated localization confers multiple functions on the protease urokinase plasminogen activator. Wells JM; Strickland S J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470 [TBL] [Abstract][Full Text] [Related]
14. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
15. Post-transcriptional regulation of gene expression in the plasminogen activation system. Montuori N; Rossi G; Ragno P Biol Chem; 2002 Jan; 383(1):47-53. PubMed ID: 11928821 [TBL] [Abstract][Full Text] [Related]
17. Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy. Weidle UH; Wöllisch E; Rønne E; Ploug M; Behrendt N; de Vries TJ; Quax PH; Verheijen JH; van Muijen GN; Ruiter DJ Ann Biol Clin (Paris); 1994; 52(11):775-82. PubMed ID: 7747886 [TBL] [Abstract][Full Text] [Related]
18. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa. Berk RS; Katar M; Dong Z; Day DE Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1561-7. PubMed ID: 11381061 [TBL] [Abstract][Full Text] [Related]
20. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. de Vries TJ; Kitson JL; Silvers WK; Mintz B Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]